Bio-Techne Releases Fourth Quarter Fiscal 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Needham Starts NeoVolta (NEOV) at Buy
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- SanDisk stock target lifted by Citi on continued demand strength
Bio-Techne Corp. (TECH) PT Raised to $175 at Deutsche Bank
August 8, 2018 7:41 AM EDTDeutsche Bank raised its price target on Bio-Techne Corp. (NASDAQ: TECH) to $175.00 (from $165.00) while maintaining a Hold rating.
... MoreBio-Techne (TECH) Tops Q4 EPS by 5c, Revenues Beat
August 7, 2018 7:04 AM EDTBio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.34, $0.05 better than the analyst estimate of $1.29. Revenue for the quarter came in at $180.3 million versus the consensus estimate of $174.77 million.
Fourth quarter organic revenue increased by 9% (15% reported) to $180.3 million. Full year organic revenues increased by 9% (14% reported) to $643.0 million.GAAP EPS was $1.07 versus $0.74 one year ago, an increase of 45% over the prior year. Full year GAAP EPS was $3.29 versus $2.03 one year ago, an increase of 62% over the prior year.Delivered a record adjusted... More